Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+20Malignant Bladder Neoplasm+16.6Malignant Pancreatic Neoplasm+10Malignant Vaginal Neoplasm+10Malignant Vulvar Neoplasm+10Malignant Esophageal Neoplasm+3.4Malignant Salivary Gland Neop…+3.3Malignant Kidney Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Ovarian Neoplasm+3.3Malignant Lung Neoplasm0Malignant Prostate Neoplasm0Malignant Rectal Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
47248
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2593939

2=Cutaneous Melanoma+2096.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7818
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2593940

3=Malignant Laryngeal Neoplasm+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3791
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
20

ranking row 2593941

4=Malignant Bladder Neoplasm+16.690Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12483
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
63.3
activityPercentile
46.7

ranking row 2593942

5=Malignant Pancreatic Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
30777
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
90
activityPercentile
80

ranking row 2593943

5=Malignant Vaginal Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
391
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
10
activityPercentile
0

ranking row 2593944

5=Malignant Vulvar Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
775
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2593945

8=Malignant Esophageal Neoplasm+3.476.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12860
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2593946

9=Malignant Salivary Gland Neoplasm+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
696
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2593947

10=Malignant Kidney Neoplasm+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12286
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56.7

ranking row 2593949

10=Malignant Mesothelioma+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2476
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2593948

10=Malignant Ovarian Neoplasm+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14657
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
73.3
activityPercentile
70

ranking row 2593950

13=Malignant Lung Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
157990
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2593951

13=Malignant Prostate Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
29554
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2593952

13=Malignant Rectal Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8535
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2593954

13=Malignant Testicular Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
344
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
6.7
activityPercentile
6.7

ranking row 2593953

17=Malignant Breast Neoplasm-3.446.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41998
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2593955

18=Malignant Liver Neoplasm-6.643.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14706
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
76.7
activityPercentile
83.3

ranking row 2593956

19=Malignant Thyroid Gland Neoplasm-6.640Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1312
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
26.7
activityPercentile
33.3

ranking row 2593957

20=Malignant Hypopharyngeal Neoplasm-6.736.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
318
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
3.3
activityPercentile
10

ranking row 2593958

20=Malignant Penile Neoplasm-6.736.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
250
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2593959

22=Hodgkin Lymphoma-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1347
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
30
activityPercentile
36.7

ranking row 2593961

22=Leukemia-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21608
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
83.3
activityPercentile
90

ranking row 2593960

22=Malignant Central Nervous System Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12901
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
70
activityPercentile
76.7

ranking row 2593962

25=Malignant Anal Neoplasm-1020Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
555
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
13.3
activityPercentile
23.3

ranking row 2593964

25=Malignant Gastric Neoplasm-1020Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12110
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
56.7
activityPercentile
66.7

ranking row 2593963

27=Non-Hodgkin Lymphoma-13.313.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21475
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
80
activityPercentile
93.3

ranking row 2593965

28=Malignant Uterine Corpus Neoplasm-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3261
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
36.7
activityPercentile
53.3

ranking row 2593966

29=Malignant Cervical Neoplasm-16.76.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3919
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
43.3
activityPercentile
60

ranking row 2593967

30=Multiple Myeloma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10809
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
53.3
activityPercentile
73.3

ranking row 2593968

31=Malignant Nasopharyngeal Neoplasm-26.60Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
598
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
16.7
activityPercentile
43.3

ranking row 2593969

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 0d3524a55579f0f5b4090d08